The components by themselves in Feldetrex have all individually been approved by the FDA but not in conjunction with each other which is why BIEI is bringing it outside the U.S. to expedite their ability to administer the drug due to less stringent guidelines; as a result, they will be able to generate revenue and fund themselves.
News 
Market Data 
Discover 
AI
